ACINX
Price
$24.50
Change
+$0.05 (+0.20%)
Updated
Sep 4 closing price
Net Assets
797.51M
OSMYX
Price
$38.74
Change
-$0.01 (-0.03%)
Updated
Sep 4 closing price
Net Assets
2.41B
Interact to see
Advertisement

ACINX vs OSMYX

ACINX vs OSMYX Comparison Chart in %
View a ticker or compare two or three
VS
ACINX vs. OSMYX commentary
Sep 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACINX is a Hold and OSMYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSMYX has more cash in the bank: 2.41B vs. ACINX (798M). ACINX pays higher dividends than OSMYX: ACINX (1.79) vs OSMYX (1.57). ACINX was incepted earlier than OSMYX: ACINX (34 years) vs OSMYX (21 years). OSMYX (1.18) is less costly to investors than ACINX (1.04). OSMYX is a more actively managed with annual turnover of: 52.00 vs. ACINX (25.00). OSMYX has a lower initial minimum investment than ACINX: OSMYX (1000) vs ACINX (2000). ACINX annual gain was more profitable for investors over the last year : 4.44 vs. OSMYX (-6.21). ACINX return over 5 years is better than : -33.28 vs. OSMYX (-37.56).
ACINXOSMYXACINX / OSMYX
Total Expense Ratio0.971.1882%
Annual Report Gross Expense Ratio1.041.1888%
Fund Existence34 years21 years-
Gain YTD7.12510.55967%
Front LoadN/AN/A-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets798M2.41B33%
Annual Yield % from dividends1.791.57114%
Returns for 1 year4.44-6.21-72%
Returns for 3 years9.13-0.12-7,353%
Returns for 5 years-33.28-37.5689%
Returns for 10 years-35.477.30-486%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XJAN39.20N/A
N/A
FT Vest US Eq Enh & Mod Buf ETF-Jan
MSLC60.85-0.24
-0.39%
Morgan Stanley Pathway Large Cap Eq ETF
PQUS28.59-0.12
-0.41%
Pictet AI Enhanced US Equity ETF
BINV45.37-0.23
-0.50%
Brandes International ETF
WDNA23.08-0.35
-1.49%
WisdomTree BioRevolution ETF